BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240320
DTEND;VALUE=DATE:20240323
DTSTAMP:20260530T105304
CREATED:20240221T060917Z
LAST-MODIFIED:20240221T061947Z
UID:5310-1710892800-1711151999@thebiocalendar.com
SUMMARY:Patients as Partners® in Clinical Research
DESCRIPTION:Demonstrating HOW Patient Involvement Gets Done to Better Support Access\, Decision-making and Accelerating Medicine Development \n\n\n\n\nPatients as Partners® in Clinical Research offers an unparalleled opportunity to hear from pharma R&D\, FDA and patient advocacy on how patient involvement gets done to drive greater efficiencies in clinical research. \nWe are delighted to continue the #AskthePatients onsite program\, now in its 10th year at Patients as Partners in Clinical Research. \n#AskthePatients offers a unique opportunity for individuals to connect with patients or caregivers who have actively participated in clinical trials in 1:1 meetings. This initiative offers valuable insights into their experiences\, challenges\, and perspectives in navigating clinical trials\, contributing to the shaping future progress.\n​​​​​​​\nAttendees will have the opportunity to sign up on site to meet with the participating patient advocates.
URL:https://thebiocalendar.com/event/patients-as-partners-in-clinical-research-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240325
DTEND;VALUE=DATE:20240326
DTSTAMP:20260530T105304
CREATED:20240119T044702Z
LAST-MODIFIED:20240119T044730Z
UID:5111-1711324800-1711411199@thebiocalendar.com
SUMMARY:RESI South
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series connects start-ups and early-stage investors and strategic channel partners. RESI maximizes fundraising companies’ efforts to find partners who are a fit for their technology and stage of development. RESI is uniquely cross-border and cross-domain\, connecting start-ups with 10 categories of global investors across the silos of drugs\, devices\, diagnostics and digital health (4 Ds). RESI caters to both the earliest stage start-ups\, those seeking grants\, seed and angel capital\, and the early-stage firms who seek series A and B funding. RESI is a unique and powerful tool for sourcing assets and advancing innovation across early-stage life science and healthcare. \n\n\n\n\n\n\nRESI South in Atlanta is particularly significant as it will showcase the burgeoning life science innovation ecosystem in the Southeastern United States. The Southeast LifeSci Investor Coalition\, representing seven southern states (AL\, FL\, GA\, NC\, SC\, TN\, and VA)\, has united to spotlight the region’s wealth of early-stage drugs\, devices\, diagnostics\, and digital health technologies. Thousands of startups are invigorating this innovation region. LSN estimates that hundreds of startups with technology transfer licenses are ready to explore the partnering opportunities that RESI South will bring. \nMore information
URL:https://thebiocalendar.com/event/resi-south/
LOCATION:Atlanta\, Atlanta\, GA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20260530T105304
CREATED:20230827T195850Z
LAST-MODIFIED:20240125T201808Z
UID:4548-1711411200-1711670399@thebiocalendar.com
SUMMARY:TRI-CON 2024
DESCRIPTION:  \nFor 3 decades\, the Precision Med TRI-CON has served as the leading international meeting place for the diagnostics and precision medicine community. Join thousands of international thought leaders to discuss the latest research\, technologies\, innovation and business models in implementing precision medicine\, biomarkers and companion diagnostics\, genomic medicine\, and precision health; innovation and market access strategies for at-home diagnostics\, point-of-care testing and molecular diagnostics for infectious diseases; liquid biopsy and advanced diagnostics for precision oncology\, including multi-cancer early detection and minimal residual disease testing. Emerging implications of faster and cheaper sequencing\, AI and digital tools\, rare disease diagnostics and gene therapies\, and spatial biology and single-cell multiomics in advancing precision medicine will be covered in 2024. Join us in sunny San Diego for the in-person networking and visionary and thought-provoking keynote discussions you’ve come to expect from the TRI-CON!
URL:https://thebiocalendar.com/event/tri-con-2024/
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/01/t2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240326T130000
DTEND;TZID=UTC:20240326T140000
DTSTAMP:20260530T105304
CREATED:20240125T211509Z
LAST-MODIFIED:20240125T211509Z
UID:5157-1711458000-1711461600@thebiocalendar.com
SUMMARY:QB3 Webinar: Anna Molofsky\, UCSF. "Neuroimmune Regulation of Brain Development and Plasticity"
DESCRIPTION:Synapse remodeling is essential to brain development\, learning\, and to maintain healthy brain function. Synapses are impacted in many diseases including autism spectrum disorders (ASD)\, epilepsy\, and schizophenia. Brain development depends on the dynamic interactions of multiple cell types\, including neurons\, astrocytes\, and microglia\, the immune cells of the brain. Our long term goal is to define how the non-neuronal elements of the brain- particularly immune and glial cells – impact brain development and function. We use transcriptomics\, mouse genetics\, and high resolution imaging to achieve these goals.
URL:https://thebiocalendar.com/event/qb3-webinar-anna-molofsky-ucsf-neuroimmune-regulation-of-brain-development-and-plasticity/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240326T160000
DTEND;TZID=America/Los_Angeles:20240326T183000
DTSTAMP:20260530T105304
CREATED:20240223T031547Z
LAST-MODIFIED:20240319T224739Z
UID:5333-1711468800-1711477800@thebiocalendar.com
SUMMARY:BVS’  Biotech Community Event at SOVA Science District\, San Diego
DESCRIPTION:We are very excited to announce our outdoor Biotech Community Event at SOVA Science District. \nOur last events were a HUGE success with 300 high-quality people registering from over 100+ companies/institutes & we will once again be inviting the entire So CA Life Science Community to attend. \nThis is a special Biotech Community Event sponsored by some of the top scientific suppliers in the industry\, along with it being a wonderful way for scientists\, entrepreneurs and science vendors to network in a relaxed evening venue. \nThe event will be a combination of vendor exhibits\, tacos and beer. \nFREE to life science job-related employees (including executives\, purchasing\, scientists\, clinical\, manufacturing\, etc.) at life science companies and research institutes. \nProduct and Service providers that sell to the life science community\, BVS and non-BVS suppliers\, lawyers\, consultants\, etc. will pay a $200.00 fee to attend. \nWe look forward to seeing you there!
URL:https://thebiocalendar.com/event/bvs-biotech-community-event-at-sova-science-district-san-diego/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/02/BVS-Biotech-Event-Flyer-03-26-24-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240328T080000
DTEND;TZID=UTC:20240328T170000
DTSTAMP:20260530T105304
CREATED:20240116T191633Z
LAST-MODIFIED:20240116T191633Z
UID:5097-1711612800-1711645200@thebiocalendar.com
SUMMARY:Boston Life Sciences Conference
DESCRIPTION:What You’ll Learn: \n\nHow does Boston’s biotech ecosystem foster a culture of innovation\, and what unique factors contribute to its success?\nHow have significant projects in the area played a role in advancing and shaping the growth and development of the biotech and life science sectors?\nWhat role does technology play in meeting tenant expectations for flexibility and adaptability in the life science workspace?\nIn what ways has the demand for flexibility influenced leasing dynamics in the Boston life science real estate market?\nHow do you anticipate the future trajectory of interest rates will impact the capitalization and financing of life science projects in Boston?\nIn what ways do changing interest rates influence investment decisions and capital allocation in the life science real estate market?\n\nHow you’ll do more business: \nConnect with industry leaders to explore emerging leasing dynamics\, gain valuable investor insights\, and discover cutting-edge innovations in workspace design. Gain insights into the trade-offs and advantages associated with advanced manufacturing techniques and Good Manufacturing Practice standards in biotech. Explore topics like sustainable facility design\, power solutions\, access considerations\, and other crucial aspects that can enhance your business strategy. \nWho attends: \nInvestors\, owners\, developers\, tenants\, end users\, brokers\, lawyers\, designers\, contractors\, architects\, property managers and more! \nWhy should you attend: \nBisnow events bring together the biggest power players in the industry to identify opportunities\, build your network\, and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than us.
URL:https://thebiocalendar.com/event/boston-life-sciences-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240402
DTEND;VALUE=DATE:20240403
DTSTAMP:20260530T105304
CREATED:20240401T193821Z
LAST-MODIFIED:20240401T193821Z
UID:5493-1712016000-1712102399@thebiocalendar.com
SUMMARY:MedExecWomen 2024 - Innovative Approaches in Medtech for the Win: A Multidisciplinary Strategy
DESCRIPTION:AGENDA\nThe agenda is being continuously updated\, please check back for speaker updates. \nThe Westin Boston Seaport District\n425 Summer Street\, Boston\, MA 02210
URL:https://thebiocalendar.com/event/medexecwomen-2024-innovative-approaches-in-medtech-for-the-win-a-multidisciplinary-strategy/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240403T130000
DTEND;TZID=UTC:20240403T140000
DTSTAMP:20260530T105304
CREATED:20240401T200909Z
LAST-MODIFIED:20240401T200924Z
UID:5503-1712149200-1712152800@thebiocalendar.com
SUMMARY:BIO 2024 Convention Preview & Partnering
DESCRIPTION:The BIO International Convention attracts 15\,000+ biotechnology and pharma leaders for one week of intensive networking to discover new opportunities and promising partnerships. Position yourself for success at this year’s event\, June 3-6\, in San Diego! BIO is where business and breakthroughs converge – and the BIO One-on-One Partnering™ system facilitates the connections that fuel our industry. \nAttend this webinar to learn more about what’s happening at BIO 2024 and what the BIO One-on-One Partnering™ system can do for your business goals. Explore the program\, networking opportunities\, partnering system fundamentals\, gain insight to best practices for partnering\, and much more! For more information and to register for BIO 2024\, please visit: convention.bio.org
URL:https://thebiocalendar.com/event/bio-2024-convention-preview-partnering/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240404T110000
DTEND;TZID=UTC:20240404T120000
DTSTAMP:20260530T105304
CREATED:20240401T194112Z
LAST-MODIFIED:20240401T194152Z
UID:5494-1712228400-1712232000@thebiocalendar.com
SUMMARY:Halloran Knowledge Hub: Live Webinar – Success Planning for an Original NDA / BLA Submission
DESCRIPTION:Join us for a live webinar on navigating New Drug Applications (NDA) and Biologics License Applications (BLA). Our experts will discuss planning strategies and share insights from recent submissions to empower you in the NDA/BLA journey. Register here! \nDetails: \n\nDate: April 4\, 2024\nTime: 11am EST\nDuration: 1 Hour (Including a Live Q&A)\n\nAudience Key Takeaways: \n\nTrigger points for NDA/BLA planning\nOrganizing teams and resources\nTools and workstreams for successful submissions
URL:https://thebiocalendar.com/event/halloran-knowledge-hub-live-webinar-success-planning-for-an-original-nda-bla-submission/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240405
DTEND;VALUE=DATE:20240411
DTSTAMP:20260530T105304
CREATED:20231102T210251Z
LAST-MODIFIED:20231231T235423Z
UID:4853-1712275200-1712793599@thebiocalendar.com
SUMMARY:The AACR Annual Meeting
DESCRIPTION:The AACR Annual Meeting is the focal point of the cancer research community\, where scientists\, clinicians\, other health care professionals\, survivors\, patients\, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology\, translational\, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
URL:https://thebiocalendar.com/event/the-aacr-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240409
DTEND;VALUE=DATE:20240412
DTSTAMP:20260530T105304
CREATED:20240401T193205Z
LAST-MODIFIED:20240401T193205Z
UID:5490-1712620800-1712879999@thebiocalendar.com
SUMMARY:Cell & Gene Meeting on the Med
DESCRIPTION:The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector\, this program features expert-led panels\, extensive one-on-one partnering capabilities\, exclusive networking opportunities\, and 60+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.\n\n\n\n\n\n\n\n\nThe 2024 Cell & Gene Meeting on the Med will be delivered in a hybrid format! This means that you can choose to travel to Italy and take part in the in-person experience at the Rome Cavalieri or alternatively\, you could opt-in to join the event virtually. Both formats provided our audience with the same robust programming that you have come to expect from Europe’s premier annual conference for the advanced therapy community!
URL:https://thebiocalendar.com/event/cell-gene-meeting-on-the-med/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240410T180000
DTEND;TZID=UTC:20240410T190000
DTSTAMP:20260530T105304
CREATED:20240327T071609Z
LAST-MODIFIED:20240327T071609Z
UID:5470-1712772000-1712775600@thebiocalendar.com
SUMMARY:From the Innovator's Workbench featuring Ted W. Love\, MD
DESCRIPTION:James H. Clark Auditorium\n318 Campus Drive Palo Alto\, CA 94305 \n“I love the capacity to intervene in a situation that could be or is grievous and turn it into something that is extraordinarily positive.” In 2014\, cardiologist and biotechnology executive Dr. Ted Love\, came out of an early retirement for the unique opportunity of leading a biotechnology startup that was investing in sickle cell disease – a life-threatening affliction\, primarily impacting people of African descent\, for which there were limited treatment options. By late 2019\, seven years after its founding\, the company\, Global Blood Therapeutics (GBT) had taken its first drug through FDA approval and brought it to market for use by children and adults. In 2022\, GBT was acquired by Pfizer. \nJoin us and hear from Ted on what inspired his journey into medicine and his subsequent foray into drug development; what it takes to shepherd a company through the arduous journey of conceiving\, developing\, and bringing a novel drug to market; and the biggest opportunities he foresees in biotechnology innovation. We’ll also discuss the tremendous challenges that result from inequities in our healthcare system and the deliberate strategies required to overcome these inequities.
URL:https://thebiocalendar.com/event/from-the-innovators-workbench-featuring-ted-w-love-md/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240411T180000
DTEND;TZID=UTC:20240411T210000
DTSTAMP:20260530T105304
CREATED:20240401T200009Z
LAST-MODIFIED:20240401T200009Z
UID:5499-1712858400-1712869200@thebiocalendar.com
SUMMARY:The GLP-1 Catalyst: Transforming Health Care Markets
DESCRIPTION:The advent of GLP-1 receptor agonists is not just a significant milestone in diabetes and obesity treatment; it presents opportunity for systemic change in disease prevention and management as well as overall health economics. But what does that mean for the health care industry as a whole? \nJoin us for a forward-looking conversation exploring the transformative ripple effects of GLP-1s. A panel of multidisciplinary experts will discuss how GLP-1 treatments can alter patient care pathways\, reduce long-term health care costs\, and improve patient outcomes on a macro scale\, while at the same time impacting payer strategies\, delivery models\, and patient engagement.
URL:https://thebiocalendar.com/event/the-glp-1-catalyst-transforming-health-care-markets/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240413
DTEND;VALUE=DATE:20240419
DTSTAMP:20260530T105304
CREATED:20240401T193344Z
LAST-MODIFIED:20240401T193344Z
UID:5491-1712966400-1713484799@thebiocalendar.com
SUMMARY:2024 AAN Annual Meeting
DESCRIPTION:The AAN Annual Meeting is the largest gathering of neurologists and neuroscience professionals and offers top-tier education\, the latest in scientific discoveries\, and an abundance of opportunities to connect with friends and colleagues from around the globe. \nApril 13-18 | Denver & Online
URL:https://thebiocalendar.com/event/2024-aan-annual-meeting/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240415
DTEND;VALUE=DATE:20240418
DTSTAMP:20260530T105304
CREATED:20240116T191717Z
LAST-MODIFIED:20240116T191717Z
UID:5098-1713139200-1713398399@thebiocalendar.com
SUMMARY:Bio-IT World Conference & Expo
DESCRIPTION:The Bio-IT World Conference & Expo is the world’s premier event showcasing the technologies and analytic approaches that solve problems\, accelerate science\, and drive the future of precision medicine. The Event unites a community of leading life sciences\, pharmaceutical\, clinical\, healthcare\, informatics\, and technology experts in the fields of biomedical research\, drug discovery & development\, and healthcare from around the world. During April 15-17\, 2024\, our 23rd annual event will once again host the conversations that connect people\, ideas\, and opportunities that are advancing research and innovation. Join your colleagues for updates from inspiring keynotes\, more than 200 presentations\, and 3 days of interactive discussion.
URL:https://thebiocalendar.com/event/bio-it-world-conference-expo-3/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240416
DTEND;VALUE=DATE:20240417
DTSTAMP:20260530T105304
CREATED:20231209T050546Z
LAST-MODIFIED:20240111T005439Z
UID:5001-1713225600-1713311999@thebiocalendar.com
SUMMARY:BioLabs Investor Day Philadelphia 2024
DESCRIPTION:More than ever\, great life science startups need extensive investor connections to be successful. That’s why BioLabs is joining forces with key local ecosystem partners — and drawing on our international network of investor relationships — to bring the money and the talent together. \nWith a successful track record of BioLabs Investor Day events across the US and Europe\, Philadelphia’s Investor Day 2024 will bring together life science investors from across the country and startups from Philly’s groundbreaking ecosystem for a day of pre-selected lightning pitches and invite-only networking.
URL:https://thebiocalendar.com/event/biolabs-investor-day-philadelphia-2024/
LOCATION:The Curtis\, 601 Walnut Street\, Philadelphia\, PA\, United States
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2024/01/sced.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240417
DTEND;VALUE=DATE:20240419
DTSTAMP:20260530T105304
CREATED:20240221T060527Z
LAST-MODIFIED:20240221T060733Z
UID:5309-1713312000-1713484799@thebiocalendar.com
SUMMARY:CMO Summit 360°
DESCRIPTION:The CMO Summit 360° ® is the largest gathering of biotech Chief Medical Officers across indications\, modalities\, company stages\, professional experience levels and geographic locations. This is the conference to connect with peers and develop the skills needed to succeed as a biotech CMO. \n\n\n\n\n\n\n\n\n2024 Key Themes Include: \n\n\n\n\n\n\n\n\nNavigating the CMO Role in 2024\n\n\n\n\n• Annual Keynote Address on the State of the Drug Development Industry\n• Lessons Learned Navigating Challenges and Pivoting as a CMO\n• Managing and Motivating a Biotech Team in 2024\n• Working Within a Budget: How to Create the Greatest Value Within a Runway Before the Next Funding Raise\n• Artificial Intelligence Keynote\n• The Role of AI in the CMO Clinical Development Toolbox \n\n\n\n\n\n\nBest Practices Managing CMO Departments\n\n\n\n\n• How CMOs Build a Network of Consultants and Support\n• How Biotechs and CROs Navigate their Relationships to Advance Clinical Development\n• Patient Engagement: Practical Approaches\n• Maximizing Regulatory Interactions\n• What CMOs Need to Know About Partnering with Hospitals & Clinical Research Sites\n• Best Practices Interacting with Boards Throughout the Biotech Lifecycle \n\n\n\n\n\n\n\n\n\n\n\n\nThe Lifecycle of a Biotech CMO\n\n\n\n\n• CEOs’ Insights on Where CMOs can Best Add Value for Companies at Different Stages\n• CMO as a Translational Scientist\n• Scaling Up Effectively as Your Biotech Company Evolves\n• Transitioning from Early Stage to Registrational/Pivotal Stage Development\n• Preparing for Launch: What CMOs Need to Know and Do \n\n\n\n\n\n\nBiotech Financing and Business Development\n\n\n\n\n• What Investors Are Looking For in 2024\n• CMO Insights and Advice on Tailoring Your Pitch to Investors\n• Best Practices Throughout the Lifecycle of Pharma-
URL:https://thebiocalendar.com/event/cmo-summit-360/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240417
DTEND;VALUE=DATE:20240419
DTSTAMP:20260530T105304
CREATED:20240307T221703Z
LAST-MODIFIED:20240308T194205Z
UID:5423-1713312000-1713484799@thebiocalendar.com
SUMMARY:Life Science Innovation Northwest 2024
DESCRIPTION:Life Science Innovation Northwest (LSINW) is the Pacific Northwest’s largest annual life science conference. This one-and-a-half-day event\, on April 17-18 at the Seattle Convention Center\, will bring our life sciences community together to discuss and feature some of the most compelling life science breakthroughs of our time. \n\nHear an inspiring keynote address from Dr. Thomas Lynch Jr.\, President & Director at Fred Hutchinson Cancer Center\nCatch Luke Timmerman’s live recording of “The Long Run Podcast” with Vineeta Agarwala\, MD\, PhD\, General Partner\, Andreessen Horowitz\nListen to 80+ company/research institution presentations from our region’s most innovative organizations\nHear panel discussions and presentations on the hottest topics including artificial intelligence\, biomanufacturing\, the current investing climate\, radical health\, and more\nAttend the Fast Pitch Showdown to learn firsthand about the up-and-coming life science companies ready to make a big impact in our community\nView poster presentations from entrepreneurs and researchers on the newest innovations and findings in our industry\nHear the latest findings from our new Economic Impact and Investor Reports as well as a presentation of this year’s Investor of the Year Award\nNetwork with hundreds of conference attendees during our many networking breaks including the afternoon coffee/ice cream break in the exhibit hall\, breakfast and lunch breaks\, and our Closing Celebration Reception!\n\nRegister today to join the growing crowd of life sciences CEOs and senior executives at our largest event of the year!
URL:https://thebiocalendar.com/event/life-science-innovation-northwest-2024/
LOCATION:Seattle Convention Center\, 705 Pike St.\, Seattle\, WA\, 98101\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240418T120000
DTEND;TZID=UTC:20240418T130000
DTSTAMP:20260530T105304
CREATED:20240328T194734Z
LAST-MODIFIED:20240328T194933Z
UID:5481-1713441600-1713445200@thebiocalendar.com
SUMMARY:Navigating Fundraising in the Life Sciences Industry
DESCRIPTION:Are you a life science startup seeking guidance on fundraising? Join us for an insightful discussion followed by an interactive Q&A session designed to help you navigate the life sciences fundraising landscape with confidence. \nDiscussion: \n\nStrategies for successful fundraising campaigns\nInsights from industry experts and seasoned entrepreneurs\nTips for crafting a compelling pitch and attracting investors\n\nExpert Speakers: \n\nAdrian Rubstein\, Founder\, Ax3.Bio\nVictoria Donovan\, Founder & CEO\, Clinically Media\nAnd More Featured Guests!\n\nDate: \n\nThursday\, April 18\, 12pm ET (60 min)
URL:https://thebiocalendar.com/event/navigating-fundraising-in-the-life-sciences-industry/
LOCATION:Online webinar
CATEGORIES:Featured
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/03/https___cdn.evbuc_.com_images_729862829_992386616393_1_original.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240418T130000
DTEND;TZID=UTC:20240418T140000
DTSTAMP:20260530T105304
CREATED:20240125T211354Z
LAST-MODIFIED:20240328T195534Z
UID:5156-1713445200-1713448800@thebiocalendar.com
SUMMARY:QB3 Webinar: Saul Villeda\, UCSF
DESCRIPTION:Aging drives cellular and cognitive impairments in the adult brain. It is imperative to gain mechanistic insight into what drives aging phenotypes in the brain in order to maintain\, and even restore\, functional integrity in the elderly. We\, and others\, have shown that systemic manipulations – such as heterochronic parabiosis (in which a young and old circulatory system are joined) and administration of young blood or exercise induced blood factors – can reverse age-related impairments in regenerative\, synaptic and inflammatory processes\, as well as rescue cognitive faculties in the aged brain. These studies have revealed an age-dependent bi-directionality in the influence of the systemic environment indicating pro-youthful factors in young blood elicit rejuvenation while pro-aging factors in old blood drive aging. It has been proposed that introducing pro-youthful factors or mitigating the effect of pro-aging factors may provide effective strategies to rejuvenate aging phenotypes in the brain. Despite this potential\, much is unknown as to the systemic and molecular mechanisms regulating pro-youthful and pro-aging effects of blood-borne factors. I will discuss work from my research group that begins to provide mechanistic insight into the systemic and molecular drivers promoting rejuvenation in the aging brain. \nWHERE & WHEN\nZoom Webinar\nThursday\, April 18\, 2024\, 1:00 to 2:00 PM PT \n\n\n\n\n\nRegister On Zoom\n\n\n\n\n\n\nABOUT THE SPEAKER\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nDr. Saul Villeda obtained his B.S. degree from the University of California Los Angeles and his PhD degree in Neuroscience from Stanford University. Dr. Villeda started his independent career at the University of California San Francisco as a Sandler Fellow\, and is now an Associate Professor in the Department of Anatomy and Endowed Chair in Biomedical Sciences.
URL:https://thebiocalendar.com/event/qb3-webinar-saul-villeda-ucsf/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240423
DTEND;VALUE=DATE:20240426
DTSTAMP:20260530T105304
CREATED:20240401T194247Z
LAST-MODIFIED:20240401T194247Z
UID:5495-1713830400-1714089599@thebiocalendar.com
SUMMARY:The World Orphan Drug Congress
DESCRIPTION:The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies\, government and regulatory authorities\, patient advocacy groups\, payers\, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. \nJoin us for three days in Boston for the most comprehensive program and inclusive gathering of rare disease stakeholders.
URL:https://thebiocalendar.com/event/the-world-orphan-drug-congress/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240424
DTEND;VALUE=DATE:20240425
DTSTAMP:20260530T105304
CREATED:20240401T193459Z
LAST-MODIFIED:20240401T193459Z
UID:5492-1713916800-1714003199@thebiocalendar.com
SUMMARY:2024 State of Possible Conference
DESCRIPTION:MassBio’s State of Possible Conference is the premier event for the Massachusetts life sciences industry. \nAttendees from the lab to the c-suite will experience a packed\, ‘can’t miss’ agenda featuring top pharmaceutical and biotech leaders taking the stage to speak to the conference theme of Meeting the Moment. Experience engaging panel discussions on surviving biotech’s choppy waters and rewriting what is possible in science\, with ample time for networking\, partnering\, and celebrating. New this year – we will recognize MassBio members during an award showcase\, including the Henri A. Termeer Innovative Leadership Award\, and host a surprise experience designed to “give back” to the community. \nRegister today to join 500+ attendees from across the ecosystem. \n2024 State of Possible Conference Speakers: \n\nDevin McCourty\, 3x Super Bowl champion and sickle cell disease advocate\nGovernor Maura Healey\, Commonwealth of Massachusetts\nJohn F. Crowley\, President & CEO\, Biotechnology Innovation Organization (BIO)\nReshma Kewalramani\, President & CEO\, Vertex Pharmaceuticals\nPeter Kolchinsky\, Managing Partner\, RA Capital Management\nTess Cameron\, Principal\, RA Capital Management\nSusan Windham-Bannister\, President & CEO\, Biomedical Growth Strategies\nKendalle Burlin O’Connell\, CEO & President\, MassBio\nPanel discussions\n\nSuccess in Choppy Waters\n\nDoug Banks\, Executive Editor\, Boston Business Journal – Moderator\nSharon Cunningham\, CEO & Co-Founder\, Shorla Oncology\nBarry Greene\, CEO\, Sage Therapeutics\nMike Nally\, CEO\, Generate Biomedicines\nDaphne Zohar\, Founder and CEO\, PureTech Health\n\n\nRewriting What is Possible\n\nChris Garabedian\, Chairman and CEO\, Xontogeny – Moderator\nAbe Ceesay\, CEO\, Rapport Therapeutics\nEmma Lees\, Ph.D\, Sr. Vice President of Research and Early Development\, Bristol Myers Squibb\nJacob Sten Petersen\, Senior Vice President\, Head of Global Nucleic Acid Therapies\, Novo Nordisk\nStan Wang\, MD\, Ph.D\, CEO & Founder\, Thymmune Therapeutics
URL:https://thebiocalendar.com/event/2024-state-of-possible-conference/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240424T080000
DTEND;TZID=UTC:20240424T120000
DTSTAMP:20260530T105304
CREATED:20240416T034938Z
LAST-MODIFIED:20240416T034938Z
UID:5552-1713945600-1713960000@thebiocalendar.com
SUMMARY:Mid-Atlantic Life Sciences & Biotech Summit
DESCRIPTION:WHAT YOU’LL LEARN AT THIS COMMERCIAL REAL ESTATE LIFE SCIENCES CONFERENCE\n\nWhat continues to drive the investment appetite for the life sciences sector within the Mid-Atlantic region?\nBetween construction costs and rising interest rates\, how has the impact of the last few months affected current projects? What strategies are being implemented to navigate through these challenges in 2024?\nHow are resilience and risk mitigation strategies being integrated into the design and development of commercial real estate for life sciences in the Mid-Atlantic?\nWho is currently putting money into life sciences and biotech facilities in DC/MD/VA and beyond? What types of deals are moving forward? What are investors and brokers seeing in terms of leasing activity?\nWhat are current tenant demands? What types of innovations\, designs and amenities are being implemented in facilities?\nHow are Mid-Atlantic life sciences companies adapting their talent retention strategies in the face of increasing competition in the industry?\nAre there certain locations that are seeing more attraction? How does this compare to the past few years?\nWhat types of economic drivers are incentivizing top companies to locate to the Mid-Atlantic?\nWhat role does collaboration and partnerships play in the development of commercial real estate projects within the Mid-Atlantic life sciences ecosystem?
URL:https://thebiocalendar.com/event/mid-atlantic-life-sciences-biotech-summit-2/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240425
DTEND;VALUE=DATE:20240426
DTSTAMP:20260530T105304
CREATED:20240410T005151Z
LAST-MODIFIED:20240410T005151Z
UID:5523-1714003200-1714089599@thebiocalendar.com
SUMMARY:2024 Align Summit
DESCRIPTION:This year’s Align Summit\, a partnering event for funders and early-stage companies\, will focus on artificial intelligence and machine learning in drug discovery and development with insights from our partners Locust Walk and McKinsey & Company. We will explore this topic through four panel discussions from the perspective of biotech or AI/ML. The Align Summit will include 50 presentations of two curated tracks — seed to Series A biotech companies and emerging companies focused on AI/ML R&D — along with all day partnering opportunities through our powerful mobile app.
URL:https://thebiocalendar.com/event/2024-align-summit/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240425T073000
DTEND;TZID=UTC:20240425T090000
DTSTAMP:20260530T105304
CREATED:20240417T215624Z
LAST-MODIFIED:20240417T215641Z
UID:5571-1714030200-1714035600@thebiocalendar.com
SUMMARY:Big4Bio CFO Reception
DESCRIPTION:  \nJami Rubin of Boundless Bio and Peter Slover from Contineum Therapeutics\nwill be sharing their stories of how they completed their recent IPO’s \nBrought to you by C3\, Latham & Watkins\, DFIN\, and Big4Bio \n  \nThursday\, April 25\, 2024\n7:30-9:00am\nLatham & Watkins Office\n12670 High Bluff Drive\nSan Diego\, CA 92130
URL:https://thebiocalendar.com/event/big4bio-cfo-reception/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240425T103000
DTEND;TZID=UTC:20240425T153000
DTSTAMP:20260530T105304
CREATED:20240416T034753Z
LAST-MODIFIED:20240416T034840Z
UID:5551-1714041000-1714059000@thebiocalendar.com
SUMMARY:New York Life Sciences & Biotech
DESCRIPTION:What You’ll Learn: \n\nHow is the capital markets slowdown and rising interest rates impacting the current growth of the biotech sector?\nUnderstand where New York ranks nationally with life sciences developments and what the future hold for this market.\nWhich life sciences developments are best in class in New York and what is driving tenants to these buildings?\nLearn which infrastructure policies are driving development activity\, project approval and fostering growth for the region’s tenants.\nWith the leasing slowdown\, how is this impacting supply and demand dynamics and how owners feel about building on spec?\nWhich design elements are in highest demand for driving leasing activity and how does this differ in New York City vs. the NY suburbs?\nWhich markets can serve as a blueprints or reference points for the future of the city’s life science developments?\n\n  \nHow you’ll do more business: Enhance your business by understanding how the New York life sciences community is growing to compete with other top biotech hubs across the country. Gain a better understanding for what tenants are looking for as they grow and expand. Additionally\, what design and development strategies are top executives implementing in these top clusters. \nWho attends: Investors\, owners\, developers\, lenders\, biotech tenants\, brokers\, public sector companies\, architects\, contractors\, engineers and property managers. \nWhy should you attend: Bisnow events bring together the biggest power players in the industry to identify opportunities\, build your network\, and expand your business. With the largest audience of commercial real estate professionals in the world\, no one knows how to help your business more than us. \nFor questions\, recommendations\, comments\, or press inquiries please email our Director of New York Events\, Chris Picher at chris.picher@bisnow.com.  \nTo request disability-related accommodations\, please contact ellie.meyer@bisnow.com no later than seven business days prior to the event.
URL:https://thebiocalendar.com/event/newyorklifesciences/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240425T130000
DTEND;TZID=UTC:20240425T140000
DTSTAMP:20260530T105304
CREATED:20240401T200132Z
LAST-MODIFIED:20240401T200132Z
UID:5500-1714050000-1714053600@thebiocalendar.com
SUMMARY:Tomorrow’s Trailblazers in Science
DESCRIPTION:Each year\, STAT chooses a new class of Wunderkinds\, showcasing stars of science and medicine who are in the midst of launching their careers. Join for a conversation with past all-star Wunderkinds to see where they are now\, how their journeys have unfolded\, and hear their most inspiring and innovative ideas. \n 
URL:https://thebiocalendar.com/event/tomorrows-trailblazers-in-science/
LOCATION:Online webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240425T153000
DTEND;TZID=UTC:20240425T183000
DTSTAMP:20260530T105304
CREATED:20240416T045246Z
LAST-MODIFIED:20240416T045246Z
UID:5559-1714059000-1714069800@thebiocalendar.com
SUMMARY:Deloitte Life Sciences Industry Accounting Guide Launch & Networking Party
DESCRIPTION:Join us for a life sciences industry networking event at Latta Wines. Enjoy the exquisite wines and food\, expand your network\, and connect with the life sciences community as we unveil the 2024 Deloitte Life Sciences Accounting Guide. \n\n\n\n\n\n\n\n\n\nLocation:\nLatta Wines\n\n\n\n\n\n\n\n\n3933 1st Avenue South\n\n\nSeattle\, Washington 98134
URL:https://thebiocalendar.com/event/deloitte-life-sciences-industry-accounting-guide-launch-networking-party/
LOCATION:Seattle\, Seattle\, WA\, United States
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2023/12/d4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20240425T163000
DTEND;TZID=America/Los_Angeles:20240425T183000
DTSTAMP:20260530T105304
CREATED:20240327T003702Z
LAST-MODIFIED:20240423T220034Z
UID:5459-1714062600-1714069800@thebiocalendar.com
SUMMARY:Outdoor Ventura BioCenter  Community Life Science Event in Thousand Oaks
DESCRIPTION:We are very excited to announce our outdoor Ventura BioCenter Life Science Community Event in Thousand Oaks. \nPlease join your colleagues from Amgen\, ADRx\, AGQ Labs\, Arcutis Biotherapeutics\, Atara Biotherapeutics\, Cal State Channel Islands\, Capsida Biotherapeutics\, Curia Global\, Hygiena\, LungLife AI\, PBS Biotech\, Takeda\, and all of the companies in the Ventura BioCenter\, along with many suppliers for a great event and get together. \nThe event will be a combination of vendor exhibits\, BBQ\, beer & wine\, and lots of networking. \nFREE to life science job-related employees (including executives\, purchasing\, scientists\, clinical\, manufacturing\, etc.) at life science companies and research institutes. \nProduct and Service providers that sell to the life science community\, BVS and non-BVS suppliers\, lawyers\, consultants\, etc. will pay a $200.00 fee to attend. \nWe look forward to seeing everyone there!
URL:https://thebiocalendar.com/event/outdoor-ventura-biocenter-community-life-science-event-in-thousand-oaks-2/
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2024/03/VBC-Vendor-Show-Flyer-04-25-24-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20240429T180000
DTEND;TZID=UTC:20240429T210000
DTSTAMP:20260530T105304
CREATED:20240401T194925Z
LAST-MODIFIED:20240401T194925Z
UID:5498-1714413600-1714424400@thebiocalendar.com
SUMMARY:STAT in DC: Policy in Health Care
DESCRIPTION:Access to health care is directly impacted by decisions being made by policymakers. STAT’s DC reporters will take a deep dive into how we can ensure patient care is remaining a top priority on the hill during this election year. Join us for an evening with patient advocates\, policymakers\, and industry leaders to discuss how policy decisions are impacting health care quality and access.
URL:https://thebiocalendar.com/event/stat-in-dc-policy-in-health-care/
END:VEVENT
END:VCALENDAR